Chemotherapy for esophageal carcinoma in India typically costs from AUD $4,600 to AUD $7,900 per cycle. Final expenses depend on the stage of cancer, chosen drug protocols, and whether generic biosimilars or branded international drugs are used. In Australia, patients often face average costs of AUD $14,100 for similar private treatments. By choosing India, Australians can save approximately 55%. Common inclusions involve the oncology consultation, hospital daycare fees, and basic drug administration.
Bookimed Expert Insight: Choosing Indian generic biosimilars can reduce total drug spend by up to 80% without compromising clinical outcomes. Large centres like Global Hospital Chennai and Manipal Hospitals offer massive scale, serving millions of patients with international quality standards. Some facilities even use advanced technologies like IBM Watson for oncology to plan precise treatment protocols. Patients benefit from specialists like Dr. Raj Nagarkar, who has performed over 50,000 cancer surgeries.
| India | Thailand | Turkey | |
| Chemotherapy for esophageal carcinoma | ≈ AUD $4,600 | ≈ AUD $5,800 | from AUD $2,400 |
No hidden fees – just official clinic prices. Pay at the clinic for Chemotherapy for esophageal carcinoma upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Chemotherapy for esophageal carcinoma and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Chemotherapy for esophageal carcinoma journey.
Dr. Ahmer Arif Shaikh is a surgical oncologist at HCG Manavata Cancer Centre. He specializes in oral cancer treatment with a focus on organ preservation. Dr. Shaikh completed fellowship training in head and neck surgical oncology at the same center. He is proficient in performing major maxillofacial and head and neck surgeries.
Dr Shruti Kate previously served as a consultant at Tata Memorial Hospital – India's premier cancer institution. She currently leads the medical oncology department at HCG Manavata Cancer Centre.
Dr Chaitainya Borde is a senior specialist at HCG Manavata Cancer Centre who has managed over 30,000 PET scans to guide precise cancer treatment.
The doctor graduated with a Bachelor of Medicine from Mysore University in 1996, followed by a Doctor of Medicine in radiotherapy from Banaras Hindu University in 2002. Further enhancing expertise, the doctor earned a Diplomate of National Board in radiotherapy in 2004.
The doctor is a member of several prestigious organizations, including the Association of Radiation Oncology of India, the Society for Neuro-Oncology, the Bangalore Oncology Group, and the Indian Association of Hyperthermia Oncology, reflecting a strong commitment to advancing the field of oncology.